Treatment-Emergent Co-Morbidities and Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide

por Lin, Yi-Ting, Huang, Yen-Chun, Liu, Chih-Kuan, Lee, Tian-Shyug, Chen, Mingchih, Chien, Yu-Ning
Publicado 2021